George is a scientifically trained executive with 40 years of experience serving in various leadership roles overseeing drug discovery and early clinical development efforts in multiple biotechnology and pharmaceutical companies. Most recently, George was previously President, CEO and CSO of Navitor Pharmaceuticals, Inc., and currently serves as a Board member and consultant. George also serves on the Boards of Nimbus Therapeutics and Riparian Pharmaceuticals as well as a consultant and scientific advisor to several biopharmaceutical companies and venture capital firms. George is the author of more than 120 peer-reviewed scientific publications, book chapters and reviews, and 38 issued U.S. and foreign patents.